CCND1 and breast cancer: Accumulating studies revealed that cyclin D1 was upregulated in various cancers, including breast cancer, melanoma, colorectal cancer, lung cancer, oral squamous cell carcinoma, as well as NPC20, 21, 22; Thus, it might be indicative of the clinical prognosis in NPC.